Anbio Biotechnology Class A Ordinary Shares (NNNN) Stock Overview
Explore Anbio Biotechnology Class A Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.
Anbio Biotechnology Class A Ordinary Shares (NNNN)
Key Financials
Key Financials
Market Cap
441.5M
P/E Ratio
50.93
EPS (TTM)
$0.07
ROE
0.27%
NNNN Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Anbio Biotechnology Class A Ordinary Shares's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NNNN on the NASDAQ shows an RSI of 29.17, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $40.79 for the NASDAQ listing.
Key metrics behind Anbio Biotechnology Class A Ordinary Shares's NASDAQ-traded stock include a P/E ratio of 50.93 and a market capitalization of 441.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NNNN on the NASDAQ.